Peter M. Clifton

Peter M. Clifton is a male healthcare provider who helps people with different health conditions like obesity, diabetes, high cholesterol, and heart diseases. He also assists with issues like hypertension, low blood sugar, and hormonal imbalances.

Peter M. Clifton uses special skills and treatments to help his patients get better. He talks to them in a way that makes them feel comfortable and safe. Patients trust him because he listens to their concerns and explains things clearly.

Peter M. Clifton stays updated with the latest medical knowledge and research to provide the best care for his patients. He reads new studies and attends conferences to learn about new treatments and technologies.

Peter M. Clifton works well with other medical professionals. He shares information and collaborates with colleagues to give his patients the best possible care. He values teamwork and respects his peers.

Peter M. Clifton's work has positively impacted many patients' lives. His treatments have helped people manage their conditions better and improve their health. Patients appreciate his dedication and expertise.

One of Peter M. Clifton's notable publications is "Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia" in The New England Journal of Medicine. He has also conducted clinical trials like "A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Mixed Dyslipidemia."

In summary, Peter M. Clifton is a caring and knowledgeable healthcare provider who uses the latest research to help his patients lead healthier lives. His work and dedication have made a positive impact on many people, and he continues to strive for excellence in his field.